Phase I Trial [resa]
5-Fluorouracil [nnon, phsu]
Cisplatin [inch, phsu]
Concurrent [tmco]
Standard [qlco]
Dose [qnco]
radiotherapy [inpr]
Japanese [popg]
Patients [podg]
Stage III [inpr]
Ii [aapp]
esophageal cancer [neop]
Japan [geoa]
5-Fluorouracil [nnon, phsu]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
days [tmco]
Cisplatin [inch, phsu]
CDDP [inch, phsu]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
days [tmco]
Plus [qlco]
Concurrent [tmco]
radiotherapy [inpr]
2 Weeks [tmco]
Planned [ftcn]
interruption [ftcn]
GY [geoa]
Standard [qlco]
Patients [podg]
esophageal cancer [neop]
Phase I Trial [resa]
Design [acty]
Maximal Tolerated Dose [qnco]
Dose-Limiting [idcn]
toxicity [qlco]
5-Fluorouracil [nnon, phsu]
days [tmco]
CDDP [inch, phsu]
days [tmco]
Plus [qlco]
Concurrent [tmco]
radiotherapy [inpr]
GY [geoa]
Japanese [popg]
Doses [qnco]
5-Fluorouracil [nnon, phsu]
CDDP [inch, phsu]
Administered [ftcn]
Concurrent [tmco]
radiotherapy [inpr]
GY [geoa]
treatment [ftcn]
Continued [idcn]
Dose-Limiting [idcn]
toxicity [qlco]
APPEAR [qlco]
Twelve [qnco]
Patients [podg]
untreated [fndg]
Clinical stage III [qlco]
Ii [aapp]
Squamous cell carcinoma [neop]
Esophageal [spco]
Study [mnob]
Six [qnco]
Patients [podg]
GIVEN [cnce]
Level 1 [inpr]
5-Fluorouracil [nnon, phsu]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
days [tmco]
CDDP [inch, phsu]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
days [tmco]
Dose-Limiting [idcn]
toxicity [qlco]
Incomplete Protocol [fndg]
treatment [ftcn]
Grade 3 Esophagitis [fndg]
Maximal Tolerated Dose [qnco]
Reach [orgf]
Level 2 [inpr]
5-Fluorouracil [nnon, phsu]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
CDDP [inch, phsu]
Mg+2 [elii, phsu]
M NOS [aapp, imft]
Complete Response [fndg]
Level 1 [inpr]
Level 2 [inpr]
Dose Level [qnco]
GY [geoa]
radiotherapy [inpr]
Recommended [idcn]
Japanese [popg]
Patients [podg]
